In vitro effect of iASPP on cell growth of oral tongue squamous cell carcinoma

Chinese Journal of Cancer Research

Volumn 26, Issue 4, 2014, Pages 382-390

  Chen, Yu ^a   Yan, Wangxiang ^a   He, Shuqi ^b   Chen, Jiechun ^a   Chen, Dan ^a   Zhang, Zhaoqiang ^c   Liu, Zhiguo ^a   Ding, Xueqiang ^a   Wang, Anxun ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^c THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; iASPP; Oral tongue squamous cell carcinoma (OTSCC); Proliferation

Indexed keywords

SMALL INTERFERING RNA;

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TRANSIENT TRANSFECTION; TUMOR SPHEROID; WESTERN BLOTTING;

EID: 84940181326     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.3978/j.issn.1000-9604.2014.07.05     Document Type: Article

References (34)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Kim SH, Cho NH, Kim K, et al. Correlational of oral tongue cancer inversion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. J Surg Oncol 2006;93:330-7.
3. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-10.
4. Bergamaschi D, Samuels Y, Sullivan A, et al. iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 2006;38:1133-41.
5. Samuels-Lev Y, O’Connor DJ, Bergamaschi D, et al. ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 2001;8:781-94.
6. Liu ZJ, Lu X, Zhong S. ASPP--Apoptotic specific regulator of p53. Biochim Biophys Acta 2005;1756:77-80.
7. Bergamaschi D, Samuels Y, O’Neil NJ, et al. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet 2003;33:162-7.
8. Slee EA, Lu X. The ASPP family: deciding between life and death after DNA damage. Toxicol Lett 2003;139:81-7.
9. Sullivan A, Lu X. ASPP: a new family of oncogenes and tumour suppressor genes. Br J Cancer 2007;96:196-200.
10. Ahn J, Byeon IJ, Byeon CH, et al. Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins. J Biol Chem 2009;284:13812-22.
11. Robinson RA, Lu X, Jones EY, et al. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73. Structure 2008;16:259-68.
12. Slee EA, Gillotin S, Bergamaschi D, et al. The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization. Oncogene 2004;23:9007-16.
13. Bergamaschi D, Samuels Y, O’Neil NJ, et al. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet 2003;33:162-7.
14. Yang JP, Hori M, Sanda T, et al. Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J Biol Chem 1999;274:15662-70.
15. Trigiante G, Lu X. ASPP [corrected] and cancer. Nat Rev Cancer 2006;6:217-26.
16. Slee EA, Lu X. The ASPP family: deciding between life and death after DNA damage. Toxicol Lett 2003;139:81-7.
17. Nexø BA, Vogel U, Olsen A, et al. Linkage disequilibrium mapping of a breast cancer susceptibility locus near RAI/PPP1R13L/iASPP. BMC Med Genet 2008;9:56.
18. Liu ZJ, Cai Y, Hou L, et al. Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells. Cancer Invest 2008;26:878-82.
19. Zhang X, Wang M, Zhou C, et al. The expression of iASPP in acute leukemias. Leuk Res 2005;29:179-83.
20. Lu B, Guo H, Zhao J, et al. Increased expression of iASPP, regulated by hepatitis B virus X protein-mediated NF-κB activation, in hepatocellular carcinoma. Gastroenterology 2010;139:2183-94.
21. Chen J, Xie F, Zhang L, et al. iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway. BMC Cancer 2010;10:694.
22. Waltregny D, Bellahcène A, Van Riet I, et al. Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J Natl Cancer Inst 1998;90:1000-8.
23. He Q, Zhou X, Li S, et al. MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway. Biochim Biophys Acta 2013;1830:5258-66.
24. Ding X, Zhang N, Cai Y, et al. Down-regulation of tumor suppressor MTUS1/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma. Mol Oncol 2012;6:73-80.
25. Liu Z, Zhang X, Huang D, et al. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance. Med Oncol 2012;29:3381-8.
26. Jiang L, Siu MK, Wong OG, et al. iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe. Clin Cancer Res 2011;17:6924-33.
27. Zhang B, Xiao HJ, Chen J, et al. Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells. Prostate Cancer Prostatic Dis 2011;14:219-24.
28. Liu WK, Jiang XY, Ren JK, et al. Expression pattern of the ASPP family members in endometrial endometrioid adenocarcinoma. Onkologie 2010;33:500-3.
29. Liu ZJ, Cai Y, Hou L, et al. Effect of RNA interference of iASPP on the apoptosis in MCF-7 breast cancer cells. Cancer Invest 2008;26:878-82.
30. Liu ZJ, Xin HM, Chen J, et al. A new strategy to resume the apoptosis activity of p53 in leukemia cell lines retaining wild-type p53. Leuk Res 2007;31:1156-8.
31. Cai Y, Qiu S, Gao X, et al. iASPP inhibits p53- independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes. Apoptosis 2012;17:777-83.
32. Chikh A, Matin RN, Senatore V, et al. iASPP/ p63 autoregulatory feedback loop is required for the homeostasis of stratified epithelia. EMBO J 2011;30:4261-73.
33. Bell HS, Ryan KM. iASPP inhibition: increased options in targeting the p53 family for cancer therapy. Cancer Res 2008;68:4959-62.
34. Liu ZJ, Zhang Y, Zhang XB, et al. Abnormal mRNA expression of ASPP members in leukemia cell lines. Leukemia 2004;18:880.